{
    "2021-12-21": [
        [
            {
                "time": "",
                "original_text": "沃森生物股价两连阴 中泰证券资管持股",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "股价",
                        "两连阴",
                        "中泰证券资管",
                        "持股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康希诺、沃森生物大幅调整，疫苗板块连续下滑",
                "features": {
                    "keywords": [
                        "康希诺",
                        "沃森生物",
                        "大幅调整",
                        "疫苗板块",
                        "连续下滑"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【东北医药刘宇腾】沃森生物（300142）的动态点评：Omicron持续发酵，弯道超车机遇凸显",
                "features": {
                    "keywords": [
                        "东北医药",
                        "刘宇腾",
                        "沃森生物",
                        "Omicron",
                        "持续发酵",
                        "弯道超车",
                        "机遇"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}